Research Project

Project Title:	Phase 2, double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of ravulizumab in adult participants with proliferative lupus nephritis (LN) or immunoglobulin A nephropathy (IgAN)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	Phase 2, double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of ravulizumab in adult participants with proliferative lupus nephritis (LN) or immunoglobulin A nephropathy (IgAN).
Lead principal investigator(s):	Olga Baraldi, Bologna Gisella Vischini, Bologna
Co-investigator(s):	Anita Campus, Bologna Beatrice Claudia Marchegiani, Bologna
Project Period:	09/2021 - 12/2025
Sponsors:	Industry